Articles tagged with “drug-discovery”

Examine the Novo Nordisk and OpenAI partnership to understand enterprise AI strategy in pharma. Explore generative AI applications in drug R&D and manufacturing

Analyze Earendil Labs' $787M funding and its implications for AI biologics. This educational report examines pharma AI investments and protein drug discovery.

Examine 2026 AI infrastructure investments in pharmaceutical R&D. This report details the Lilly-NVIDIA lab, Earendil funding, and GPU compute deployments.

Learn how pharma companies transition to AI operating models. Compare Moderna's workforce education, Sanofi's enterprise integration, and BMS's predictive R&D.

Compare AI research assistants for drug discovery. Examine how Causaly, Elicit, Consensus, and Semantic Scholar synthesize biomedical literature for R&D.

Examine how AI hallucinations affect drug discovery. Review real examples of LLM errors in pharma R&D and explore practical detection and mitigation methods.

Examine Bristol Myers Squibb's Predict First strategy for drug discovery. Learn how BMS integrates AI to augment scientific decision-making and R&D efficiency.

Examine the pharmaceutical AI strategy roadmap for scaling digital transformation. Learn about enterprise data infrastructure, LLMOps, and GxP compliance.

Analyze the pharmaceutical AI skills gap and workforce upskilling strategies. Review regulatory impacts, training models, and ROI metrics for R&D teams.

Explore Claude for Healthcare and Life Sciences capabilities. Covers HIPAA-compliant AI, Opus 4.5 integration, CMS data connectors, and drug discovery workflows

Analyze AI integration in pharma IT architecture, from R&D to supply chain. Review key data on MLOps, clinical trial efficiency, and FDA guidance.

An in-depth analysis of Montreal's biotech ecosystem (updated April 2026). Key companies, startups, research institutions, and the economic drivers of this top life sciences hub — including the latest funding rounds, clinical milestones and the Quebec Life Sciences Strategy 2025–2028.

Learn how Retrieval-Augmented Generation (RAG) connects ELN, LIMS, and institutional knowledge for drug discovery. Updated for 2026 with FDA/EMA AI guidelines, Benchling AI agents, GraphRAG, and latest market data.

An educational guide to making your biotech AI-ready. Explore essential data infrastructure fixes for data quality, integration, compute, and governance — updated for 2026 with the latest on pharma supercomputers, FDA/EMA AI guidance, and industry best practices.

Learn how AI, LLMs, and agentic AI can build a "Second Brain" for pharma R&D. Updated for 2026 with GraphRAG benchmarks, FDA AI guidance, and enterprise deployment patterns for searchable institutional memory in drug discovery.

Learn how biotech knowledge graphs are built for drug discovery. This guide covers architecture patterns (ETL, ELT, GraphRAG) for integrating compounds, assays, and targets, with 2026 updates on LLM integration and FAIR standards.

Learn about Causaly Pipeline Graph and Agentic Research, AI platforms integrating competitive intelligence and knowledge graphs for pharma R&D. Updated April 2026 with market data, FDA guidance, and platform evolution.

Explore San Diego's biotech hub, a top 3 U.S. cluster. Updated for 2026 with $4.8B VC funding data, NIH funding crisis impact, major acquisitions (Avidity $12B, Poseida $1.5B), and company updates for Illumina, Neurocrine, Halozyme

A technical overview of Claude Opus 4.5 and 4.6, state-of-the-art AI models for coding. Learn their capabilities for software development in healthcare and pharma. Updated February 2026.

Updated April 2026 analysis of Google's Gemini 3/3.1 Pro AI for healthcare, pharma, and biotech. Covers MedGemma 1.5, HIMSS 2026 deployments, Isomorphic Labs trials, and FDA/EU regulatory developments.

Learn why the drug development timeline averages 10-15 years. Updated for 2026 with AI drug discovery milestones, ICH E6(R3), FDA AI guidance, and latest cost and success rate data. Covers every stage from discovery through approval.

An in-depth analysis of the leaders in pharma digital transformation, examining the strategies of companies like AstraZeneca, Roche, Pfizer, Eli Lilly, and Sanofi with AI, generative AI, and cloud technologies — updated with 2025-2026 developments including Lilly's $1B NVIDIA AI lab and FDA AI guidance.

Learn how IBM Quantum is applied in pharmaceutical R&D. This guide covers molecular simulation, hybrid workflows, the Nighthawk and Starling processors, and key partnerships with Moderna, Algorithmiq, and Cleveland Clinic.

Updated 2026 guide to finding drugs in the clinical pipeline (Phase I-III). Learn to use ClinicalTrials.gov (550K+ studies), CTIS, commercial databases, and AI-powered tools like Pharmaprojects+ and TuneLab.

Explore our 2025 analysis of the top 25 pharmaceutical companies by AI patent filings. Learn who leads in AI R&D, key technology areas, and strategic trends.

Explore the top MCP servers for biotech. Learn how the Model Context Protocol connects AI agents and LLMs to critical databases for genomics and drug discovery.

Explore the exponential rise in AI compute demand in biotech. This 2025 report analyzes key statistics, infrastructure needs, and trends in drug discovery and g

An educational guide to HPC in life sciences. We review top lab IT specialists and solutions for genomics, drug discovery, and bioinformatics data analysis.

Updated 2026: Learn what NVIDIA BioNeMo is and how it accelerates drug discovery. This guide explains its components, latest models (RNAPro, ReaSyn v2), the $1B Lilly partnership, and deployment for generative AI in biopharma.

Explore the technical architecture of RLHF for drug discovery. Learn how reward models and policy optimization align generative AI with expert chemist feedback, with 2025-2026 clinical validation data.

Learn the end-to-end drug development pipeline, from initial drug discovery and preclinical research to Phase I-IV clinical trials and final FDA approval. Updated for 2026 with latest success rates, AI drug discovery progress, and regulatory developments.

Learn how to build robust LLM evaluation frameworks for biotech. Updated for 2026 with GPT-5, Med-Gemini, HealthBench results, FDA guidance, and the latest biomedical benchmarks including BLUE, BLURB, and hallucination detection frameworks.

An analysis of leading software for molecular modeling and simulation. Learn about features, theoretical methods (MD, QM), performance, and use cases.

An in-depth technical comparison of five cheminformatics platforms (RDKit, ChemAxon, OpenEye, Schrödinger, BIOVIA), evaluating SAR/QSAR, ADMET prediction, virtual screening, and chemical library management. Updated for 2026 with Certara-ChemAxon acquisition, ROCS X launch, and AI integration trends.

Learn about the specialized software tools used across the drug development lifecycle, from discovery and preclinical research to manufacturing and commercialization. Updated for 2026 with ICH E6(R3), DSCSA compliance deadlines, IDMP/PMS timelines, and the latest in AI-driven drug design.

Profiles of leading US researchers and industry pioneers applying generative AI to pharmaceutical R&D, drug discovery, protein design, and clinical trials – updated with 2025-2026 milestones including Phase II/III results, major funding rounds, and regulatory breakthroughs.

Examines the key scientific journals and trade publications in the pharma and biotech industries, covering peer-review, access models, and target audience.

Updated 2026 survey of global online degrees and certificates in AI for pharmaceutical science. Compare programs by level, curriculum, cost, and duration – including new offerings from UCSF, Yale, and LIU.

This article details AI applications in pharmaceutical business intelligence, covering drug discovery, clinical trials, supply chain, real-world evidence, and market intelligence.

Explore key software needs, technology stacks, and specific tools like AI-driven drug design and cheminformatics in pharmaceutical software development.

Learn why new drug development takes over a decade, discussing the high attrition rates, extensive research, and regulatory hurdles involved in bringing medicines to market.

This article lists 10 free generative AI courses for pharmaceutical professionals. Learn LLMs, prompt engineering, and AI applications in drug R&D.

How AI leaders like Amodei, Hassabis, and Huang are accelerating drug discovery, genomics, and life science breakthroughs—compressing decades into years. Updated January 2026 with AlphaFold 3, Claude for Life Sciences, NVIDIA Evo 2, and $3B+ pharma partnerships.

A technical comparison of AI agents and AI workflows in pharmaceutical IT, with use cases, pros and cons, and adoption trends for U.S. pharma.

A detailed survey of large language model benchmarks in life sciences, covering biomedical NLP, drug discovery, and genomics, with industry use cases and top model performance.

An exploration of how artificial intelligence is revolutionizing drug development processes, from target identification to clinical trials, with focus on implementation strategies and success metrics.

A comprehensive guide to how Amazon Web Services (AWS) is transforming pharmaceutical operations from drug discovery to manufacturing, with real-world case studies from Pfizer, Moderna, Merck, and more.

Explore real-world case studies of how pharmaceutical companies are leveraging big data, AI, and cloud computing across the drug lifecycle - from discovery to marketing - with measurable outcomes and lessons learned.

A comprehensive exploration of generative AI proof of concepts in pharmaceutical research, examining real-world applications, implementation strategies, and measurable outcomes across the drug development pipeline.

A comprehensive analysis of how Google Cloud Platform (GCP) is revolutionizing pharmaceutical operations, from AI-powered drug discovery to clinical trial management and regulatory compliance.

An in-depth analysis of IBM's contributions to pharmaceutical innovation, from AI-powered drug discovery and hybrid cloud infrastructure to regulatory compliance and security solutions.

An in-depth exploration of how pharmaceutical companies leverage Microsoft Azure's cloud platform for drug discovery, clinical trials, manufacturing, and regulatory compliance, with real-world case studies and implementation strategies.

A comprehensive analysis of how pharmaceutical and biotech companies are leveraging NVIDIA's latest H100 and Blackwell GPUs to accelerate drug discovery, protein structure prediction, and AI-driven research, with detailed case studies from leading companies.

An in-depth analysis of the leading AI consulting firms serving U.S. pharmaceutical companies, highlighting their focus areas, technologies, and recent activities in drug discovery, compliance, efficiency, and commercial applications.

An in-depth exploration of how data science is revolutionizing the life sciences industry, from drug discovery to clinical trials, with real-world applications and case studies. Updated January 2026 with latest FDA AI guidance, Insilico Medicine Phase IIa results, and major industry consolidations.

A comprehensive overview of the most influential open-source software tools transforming pharmaceutical research, development, and manufacturing, from cheminformatics to clinical data management and regulatory compliance.